Showing results (41-50 of 316) with videos related to
Sort By:
Pageof 32
Rheumatology (Oxford, England)|February 2, 2021
Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centersGiulia Camilla Varnier, Alessandro Consolaro, Susan Maillard, et al.Hematology/Oncology Clinics of North America|October 14, 2015
Macrophage Activation SyndromeAngelo Ravelli, Sergio Davì, Francesca Minoia, et al.Arthritis Care & Research|January 11, 2022
Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote MonitoringE H Pieter van Dijkhuizen, Francesca Ridella, Roberta Naddei, et al.International Reviews of Immunology|January 19, 2012
Severe combined immunodeficiences: new and old scenariosGiuseppina Aloj, Giuliana Giardino, Leopoldo Valentino, et al.Children (Basel, Switzerland)|October 28, 2023
Advances in the Diagnosis and Treatment of Enthesitis-Related ArthritisSimona Di Gennaro, Gennaro Di Matteo, Gianmarco Stornaiuolo, et al.Pediatric Rheumatology Online Journal|July 13, 2020
Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two casesRiccardo Papa, Valentina Natoli, Roberta Caorsi, et al.Best Practice & Research. Clinical Rheumatology|May 19, 2018
Recent therapeutic advances in juvenile idiopathic arthritisGabriella Giancane, Alessandra Alongi, Silvia Rosina, et al.Clinical and Experimental Rheumatology|October 17, 2013
Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritisSara Verazza, Giorgia Negro, Denise Marafon, et al.Neuroimmunomodulation|September 18, 2014
Glucocorticoids in juvenile idiopathic arthritisBenedetta Schiappapietra, Giulia Varnier, Silvia Rosina, et al.Frontiers in Pharmacology|December 22, 2016
IL-1 Inhibition in Systemic Juvenile Idiopathic ArthritisGabriella Giancane, Francesca Minoia, Sergio Davì, et al.Pageof 32